2nd Quarter - Report
CHAMBER HILL STRATEGIES for SAGHMOS THERAPEUTICS, INC.
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Prevention of contrast-induced acute kidney injury and major adverse renal and cardiac events after percutaneous coronary intervention.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BARTLETT New | Counsel, U.S. House of Representatives, Committee on Energy and Commerce |
| JENNIFER BELL New | Health Policy Advisor, Sen. Finance Committee |
| ANNA KATHERINE WEINSTEIN New | — |
Health Issues HCR
Issues related to the policies proposed in the 21st Century Cures 2.0 Concept Paper. Education; and awareness, generally, regarding treatment of contrast-induced acute kidney injury after percutaneous coronary intervention.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BARTLETT New | Counsel, U.S. House of Representatives, Committee on Energy and Commerce |
| JENNIFER BELL New | Health Policy Advisor, Sen. Finance Committee |
| ANNA KATHERINE WEINSTEIN New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.